95 related articles for article (PubMed ID: 12694260)
1. Co-administration of Flt-3 ligand counteracts the actions of thrombopoietin in myelosuppressed rhesus monkeys.
Hartong SC; Neelis KJ; Wagemaker G
Br J Haematol; 2003 Apr; 121(2):359-67. PubMed ID: 12694260
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
Neelis KJ; Hartong SC; Egeland T; Thomas GR; Eaton DL; Wagemaker G
Blood; 1997 Oct; 90(7):2565-73. PubMed ID: 9326222
[TBL] [Abstract][Full Text] [Related]
3. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high dose total-body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys.
Neelis KJ; Dubbelman YD; Wognum AW; Thomas GR; Eaton DL; Egeland T; Wagemaker G
Exp Hematol; 1997 Sep; 25(10):1094-103. PubMed ID: 9293907
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
[TBL] [Abstract][Full Text] [Related]
5. Lack of efficacy of thrombopoietin and granulocyte-macrophage colony-stimulating factor after total body irradiation and autologous bone marrow transplantation in Rhesus monkeys.
Hartong SC; Neelis KJ; Visser TP; Wagemaker G
Exp Hematol; 2000 Jul; 28(7):753-9. PubMed ID: 10907636
[TBL] [Abstract][Full Text] [Related]
6. Prevention of thrombocytopenia by thrombopoietin in myelosuppressed rhesus monkeys accompanied by prominent erythropoietic stimulation and iron depletion.
Neelis KJ; Qingliang L; Thomas GR; Cohen BL; Eaton DL; Wagemaker G
Blood; 1997 Jul; 90(1):58-63. PubMed ID: 9207438
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of recombinant thrombopoietin in murine and nonhuman primate models for radiation-induced myelosuppression and stem cell transplantation.
Wagemaker G; Neelis KJ; Hartong SC; Wognum AW; Thomas GR; Fielder PJ; Eaton DL
Stem Cells; 1998; 16(6):375-86. PubMed ID: 9831863
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of recombinant TPO in murine And nonhuman primate models for myelosuppression and stem cell transplantation.
Wagemaker G; Neelis KJ; Hartong SCC ; Wognum AW; Thomas GR; Fielder PJ; Eaton DL
Stem Cells; 1998; 16 Suppl 2():127-41. PubMed ID: 11012185
[TBL] [Abstract][Full Text] [Related]
9. A single dose of thrombopoietin shortly after myelosuppressive total body irradiation prevents pancytopenia in mice by promoting short-term multilineage spleen-repopulating cells at the transient expense of bone marrow-repopulating cells.
Neelis KJ; Visser TP; Dimjati W; Thomas GR; Fielder PJ; Bloedow D; Eaton DL; Wagemaker G
Blood; 1998 Sep; 92(5):1586-97. PubMed ID: 9716586
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation.
Mouthon MA; Van der Meeren A; Gaugler MH; Visser TP; Squiban C; Gourmelon P; Wagemaker G
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):867-75. PubMed ID: 10098443
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic Effect of Combined Cytokines on Nonhuman Primate Model of Severe Haemopoietic Acute Radiation Sickness].
Ma YC; Li M; Xing S; Xiong GL; Shen X; Chen Q; Cong YW; Wang JX; Zhu NK; Yu ZY; Zhang XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):573-9. PubMed ID: 27151032
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
[TBL] [Abstract][Full Text] [Related]
13. The combined administration of daniplestim and Mpl ligand augments the hematopoietic reconstitution observed with single cytokine administration in a nonhuman primate model of myelosuppression.
Farese AM; MacVittie TJ; Lind LB; Smith WG; McKearn JP
Stem Cells; 1998; 16 Suppl 2():143-54. PubMed ID: 11012186
[TBL] [Abstract][Full Text] [Related]
14. 5-Androstene-3β,17β-diol promotes recovery of immature hematopoietic cells following myelosuppressive radiation and synergizes with thrombopoietin.
Aerts-Kaya FS; Visser TP; Arshad S; Frincke J; Stickney DR; Reading CL; Wagemaker G
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e401-7. PubMed ID: 22672754
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
[TBL] [Abstract][Full Text] [Related]
16. Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors.
Li K; Yang M; Lam AC; Yau FW; Yuen PM
Cell Transplant; 2000; 9(1):125-31. PubMed ID: 10784074
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic recovery following autologous bone marrow transplantation in a nonhuman primate: effect of variation in treatment schedule with PEG-rHuMGDF.
Farese AM; MacVittie TJ; Roskos L; Stead RB
Stem Cells; 2003; 21(1):79-89. PubMed ID: 12529554
[TBL] [Abstract][Full Text] [Related]
18. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
[TBL] [Abstract][Full Text] [Related]
19. Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice.
Kabaya K; Shibuya K; Torii Y; Nitta Y; Ida M; Akahori H; Kato T; Kusaka M; Miyazaki H
Bone Marrow Transplant; 1996 Dec; 18(6):1035-41. PubMed ID: 8971370
[TBL] [Abstract][Full Text] [Related]
20. New TPO treatment schedules of increased safety and efficacy: pre-clinical validation of a thrombopoiesis simulation model.
Skomorovski K; Harpak H; Ianovski A; Vardi M; Visser TP; Hartong SC; van Vliet HH; Wagemaker G; Agur Z
Br J Haematol; 2003 Nov; 123(4):683-91. PubMed ID: 14616973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
